A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant
PHASE2
This is a phase II open label trial designed to evaluate the efficacy of Ta...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation
N/A
Naïve CD4+ helper T (Th) cells, upon encountering their cognate antigens pr...
Status
Completed
Location
Rheumatology department - Bordeaux University Hospital
Start Date
2014-09
Trial ID
NCT02569736
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
PHASE3
This open-label study will evaluate the efficacy and safety of tocilizumab ...
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
PHASE2
PALETTE is a perpetual adaptive platform to efficiently study sepsis interv...
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs
PHASE3
This multicenter, open-label, single arm study will assess the safety and e...